Opening stock page...
Fetching company snapshot, pricing, and intelligence.
AI confidence 70% · prior close shown (market closed)
ABBOTT LABORATORIES shows stable business momentum based on AlphaOS pipeline evidence, with mixed management execution.
Why it matters: Revenue +13% YoY in Q2 FY2026.
1 signal not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 0d ago
ABT's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on ABT.
Free accounts see more of this; Premium sees all of it.
Reported figures for ABBOTT LABORATORIES — research only, not investment advice.
Updated
What happened recently for ABBOTT LABORATORIES (ABT) — events, not interpretation.
Research & analysis only — not investment advice.
AlphaOS industries
Investment snapshot
ABT's AI investment thesis
Upgrade to Premium for ABT's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$101.29
Market cap
$176.43B
Profitable
Yes
Revenue $12.59B
Net income
$928.00M
FY Sep 19, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for ABBOTT LABORATORIES — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow ABBOTT LABORATORIES through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.